Beijing Strong Biotechnologies Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Strong Biotechnologies Inc with three other
companies in this sector in CHINA :
Guangdong Hybribio Biotech Co Ltd
sales of 729.39 million Chinese Renmimbi [US$106.84 million]
of which 100%
was Molecular Diagnostic Reagents and Suppor),
DA AN Gene Co.,Ltd. Of Sun Yat-Sen University
(1.10 billion Chinese Renmimbi [US$160.87 million]
of which 96%
was Biological Products), and
Getein Biotech Inc
(968.20 million Chinese Renmimbi [US$141.82 million]
of which 80%
was In-vitro diagnostics).
Beijing Strong Biotechnologies Inc reported sales of 840.86 million Chinese Renmimbi (US$123.17 million)
December of 2019.
increase of 8.6%
versus 2018, when the company's sales were 774.18 million Chinese Renmimbi.
Sales at Beijing Strong Biotechnologies Inc have increased during each of the previous five years
(and since 2014, sales have increased a total of 65%).